Literature DB >> 18753866

Effect of tuberculosis on the survival of HIV-infected men in a country with low tuberculosis incidence.

Hugo López-Gatell1, Stephen R Cole, Joseph B Margolick, Mallory D Witt, Jeremy Martinson, John P Phair, Lisa P Jacobson.   

Abstract

Evidence regarding the effect of tuberculosis (TB) on HIV disease progression at the population level remains inconclusive. We estimated the effect of incident TB on time to AIDS-related death, using a marginal structural Cox model. Between 1984 and 2005, 2882 HIV-infected men in the Multicenter AIDS Cohort Study contributed 21 914 person-years while followed for a median of 5.4 years. At study entry, the median CD4 cell count and HIV-1 RNA viral load were 533 cells/microl (interquartile range: 365-737) and 12, 953 copies/ml (interquartile range: 2453-48 540), respectively. This study was performed in a setting with a modest exposure to HAART; 8295 of 23 801 (35%) person-years were followed during the HAART era. Fifteen men incurred incident TB, yielding a TB incidence of 7 (95% confidence interval: 4-14) per 10 000 person-years and 1072 died of AIDS-related causes. Accounting for potential confounders, including CD4 cell count and viral load, the hazard of AIDS-related death was 2.4 times more for the person-time with TB compared to the person-time without TB (95% confidence interval: 1.2-4.7). Results underscore the importance of avoiding TB by using preventive interventions such as treatment of latent TB infection, particularly in populations with a large prevalence of HIV/TB co-infected individuals.

Entities:  

Mesh:

Year:  2008        PMID: 18753866      PMCID: PMC3079345          DOI: 10.1097/QAD.0b013e32830e010c

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  22 in total

1.  Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men.

Authors:  M A Hernán; B Brumback; J M Robins
Journal:  Epidemiology       Date:  2000-09       Impact factor: 4.822

2.  Association between tuberculosis and HIV disease progression in a high tuberculosis prevalence area.

Authors:  M Badri; R Ehrlich; R Wood; T Pulerwitz; G Maartens
Journal:  Int J Tuberc Lung Dis       Date:  2001-03       Impact factor: 2.373

3.  Guideline for flow cytometric immunophenotyping: a report from the National Institute of Allergy and Infectious Diseases, Division of AIDS.

Authors:  T Calvelli; T N Denny; H Paxton; R Gelman; J Kagan
Journal:  Cytometry       Date:  1993-10

4.  Impact of pulmonary tuberculosis on survival of HIV-infected adults: a prospective epidemiologic study in Uganda.

Authors:  C C Whalen; P Nsubuga; A Okwera; J L Johnson; D L Hom; N L Michael; R D Mugerwa; J J Ellner
Journal:  AIDS       Date:  2000-06-16       Impact factor: 4.177

5.  Determining the effect of highly active antiretroviral therapy on changes in human immunodeficiency virus type 1 RNA viral load using a marginal structural left-censored mean model.

Authors:  Stephen R Cole; Miguel A Hernán; Kathryn Anastos; Beth D Jamieson; James M Robins
Journal:  Am J Epidemiol       Date:  2007-05-02       Impact factor: 4.897

Review 6.  Virological and immunological impact of tuberculosis on human immunodeficiency virus type 1 disease.

Authors:  Zahra Toossi
Journal:  J Infect Dis       Date:  2003-09-30       Impact factor: 5.226

7.  Mycobacterium tuberculosis and its purified protein derivative activate expression of the human immunodeficiency virus.

Authors:  M M Lederman; D L Georges; D J Kusner; P Mudido; C Z Giam; Z Toossi
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1994-07

8.  The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants.

Authors:  R A Kaslow; D G Ostrow; R Detels; J P Phair; B F Polk; C R Rinaldo
Journal:  Am J Epidemiol       Date:  1987-08       Impact factor: 4.897

9.  1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults.

Authors: 
Journal:  MMWR Recomm Rep       Date:  1992-12-18

10.  Impact of tuberculosis on HIV disease progression in persons with well-documented time of HIV seroconversion.

Authors:  Julia Del Amo; Santiago Pérez-Hoyos; Ildefonso Hernández Aguado; Mercedes Díez; Jesús Castilla; Kholoud Porter
Journal:  J Acquir Immune Defic Syndr       Date:  2003-06-01       Impact factor: 3.731

View more
  18 in total

1.  Multidrug-Resistant Tuberculosis in Patients with Human Immunodeficiency Virus. Management Considerations within High-resourced Settings.

Authors:  John W Wilson; Diana M Nilsen; Suzanne M Marks
Journal:  Ann Am Thorac Soc       Date:  2020-01

Review 2.  Seventy Years of Tuberculosis Prevention: Efficacy, Effectiveness, Toxicity, Durability, and Duration.

Authors:  Nicole Salazar-Austin; David W Dowdy; Richard E Chaisson; Jonathan E Golub
Journal:  Am J Epidemiol       Date:  2019-12-31       Impact factor: 4.897

Review 3.  The role of coinfections in HIV epidemic trajectory and positive prevention: a systematic review and meta-analysis.

Authors:  Ruanne V Barnabas; Emily L Webb; Helen A Weiss; Judith N Wasserheit
Journal:  AIDS       Date:  2011-08-24       Impact factor: 4.177

4.  A randomized trial of punctuated antiretroviral therapy in Ugandan HIV-seropositive adults with pulmonary tuberculosis and CD4⁺ T-cell counts of ≥ 350 cells/μL.

Authors:  M W Nanteza; H Mayanja-Kizza; E Charlebois; P Srikantiah; R Lin; E Mupere; P Mugyenyi; W H Boom; R D Mugerwa; D V Havlir; C C Whalen
Journal:  J Infect Dis       Date:  2011-09-15       Impact factor: 5.226

5.  Effects of antiretroviral therapy on immune function of HIV-infected adults with pulmonary tuberculosis and CD4+ >350 cells/mm3.

Authors:  Christina L Lancioni; C Scott Mahan; Denise F Johnson; Maria Walusimbi; Keith A Chervenak; Sophie Nalukwago; Edwin Charlebois; Diane Havlir; Harriet Mayanja-Kizza; Christopher C Whalen; W Henry Boom
Journal:  J Infect Dis       Date:  2011-04-01       Impact factor: 5.226

6.  Prevalent tuberculosis at HIV diagnosis in Rio de Janeiro, Brazil: the TB/HIV in Rio (THRio) Cohort.

Authors:  Valeria Saraceni; Silvia Cohn; Solange C Cavalcante; Antonio G F Pacheco; Lawrence H Moulton; Richard E Chaisson; Betina Durovni; Jonathan E Golub
Journal:  J Acquir Immune Defic Syndr       Date:  2014-09-01       Impact factor: 3.731

7.  Reactivation of latent tuberculosis in cynomolgus macaques infected with SIV is associated with early peripheral T cell depletion and not virus load.

Authors:  Collin R Diedrich; Joshua T Mattila; Edwin Klein; Chris Janssen; Jiayao Phuah; Timothy J Sturgeon; Ronald C Montelaro; Philana Ling Lin; Joanne L Flynn
Journal:  PLoS One       Date:  2010-03-10       Impact factor: 3.240

8.  Systemic immune activation and microbial translocation in dual HIV/tuberculosis-infected subjects.

Authors:  Zahra Toossi; Nicholas T Funderburg; Sohani Sirdeshmuk; Christopher C Whalen; Maria W Nanteza; Denise F Johnson; Harriet Mayanja-Kizza; Christina S Hirsch
Journal:  J Infect Dis       Date:  2013-03-11       Impact factor: 5.226

9.  Effects of tuberculosis on the kinetics of CD4(+) T cell count among HIV-infected patients who initiated antiretroviral therapy early after tuberculosis treatment.

Authors:  Nam Su Ku; Jin Ok Oh; So Youn Shin; Sun Bean Kim; Hye-won Kim; Su Jin Jeong; Sang Hoon Han; Young Goo Song; June Myung Kim; Jun Yong Choi
Journal:  AIDS Res Hum Retroviruses       Date:  2012-09-11       Impact factor: 2.205

Review 10.  Epidemiology of HIV-associated tuberculosis.

Authors:  Stephen D Lawn; Gavin Churchyard
Journal:  Curr Opin HIV AIDS       Date:  2009-07       Impact factor: 4.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.